DL cholesterol apheresis treatment for diabetic nephropathy with severe urinary protein: a multicenter prospective study
Not Applicable
Completed
- Conditions
- Diabetic nephropathy
- Registration Number
- JPRN-UMIN000014875
- Lead Sponsor
- Division of Nephrology, Kanazawa University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 42
Inclusion Criteria
Not provided
Exclusion Criteria
-Dialysis patients -Post renal transplantation or nephrectomy -Past history undergoing LDL apheresis -Undergoing surgical procedure including revascularization within 6 month before enrollment -proliferating diabetic retinopathy or severe diabetic neuropathy -Peripheral artery disease (Rutherford class 5 or more) or post amputation
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method